Report Detail
Global Personalized Cancer Medicine Market 2023 by Company, Regions, Type and Application, Forecast to 2029
- RnM3624861 |
- 15 October, 2023 |
- Global |
- 120 Pages |
- GIR (Global Info Research) |
- Other
According to our (Global Info Research) latest study, the global Personalized Cancer Medicine market size was valued at USD 166370 million in 2022 and is forecast to a readjusted size of USD 366720 million by 2029 with a CAGR of 12.0% during review period.
Personalized cancer medicine, also known as targeted therapies or precision medicines, are medications designed to specifically target the unique genetic or molecular characteristics of an individual patient's cancer. These drugs are a central component of personalized cancer medicine and are chosen based on the genomic and molecular profiling of the patient's tumor.
Immunotherapies: While not traditional targeted therapies, immunotherapies like immune checkpoint inhibitors are another form of personalized cancer treatment. These drugs enhance the patient's immune system to recognize and attack cancer cells, and they can be tailored to patients based on their tumor's molecular characteristics.
Personalized cancer treatment drugs have revolutionized cancer care by allowing oncologists to tailor treatment plans to the individual characteristics of each patient's cancer. This approach holds great promise for improving outcomes and reducing the side effects associated with traditional cancer treatments. However, ongoing research and advancements are needed to expand the repertoire of targeted therapies and ensure that they are accessible to more cancer patients.
In the global market, the core manufacturers of Precision Cancer Medicine (Personalised Cancer Medicine) are AbbVie, Johnson & Johnson, Novartis, and others. The top three players within this industry account for about 30% of the market share. North America, Europe, and Asia Pacific are the major manufacturing regions for this product, with North America accounting for over 50% of the global market share. The product can be classified on the basis of treatment into immunotherapy and targeted therapy drugs. The product is widely used in the treatment of lung, breast, prostate, blood and other cancers.
The Global Info Research report includes an overview of the development of the Personalized Cancer Medicine industry chain, the market status of Lung Cancer (Cancer Immunotherapy, Targeted Therapy), Breast Cancer (Cancer Immunotherapy, Targeted Therapy), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Personalized Cancer Medicine.
Regionally, the report analyzes the Personalized Cancer Medicine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Personalized Cancer Medicine market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Personalized Cancer Medicine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Personalized Cancer Medicine industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Method (e.g., Cancer Immunotherapy, Targeted Therapy).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Personalized Cancer Medicine market.
Regional Analysis: The report involves examining the Personalized Cancer Medicine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Personalized Cancer Medicine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Personalized Cancer Medicine:
Company Analysis: Report covers individual Personalized Cancer Medicine players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Personalized Cancer Medicine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Lung Cancer, Breast Cancer).
Technology Analysis: Report covers specific technologies relevant to Personalized Cancer Medicine. It assesses the current state, advancements, and potential future developments in Personalized Cancer Medicine areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Personalized Cancer Medicine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Personalized Cancer Medicine market is split by Method and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Method, and by Application in terms of value.
Market segment by Method
Cancer Immunotherapy
Targeted Therapy
Market segment by Application
Lung Cancer
Breast Cancer
Prostate Cancer
Blood-related Cancer
Other
Market segment by players, this report covers
AbbVie
Johnson & Johnson
Novartis
Gilead Sciences
Roche
Bristol-Myers Squibb
Amgen
AstraZeneca
Merck & Co
Takeda
Merck KGaA
Seagen
Eli Lilly
Ono Pharmaceutical
Pfizer
GSK
Exelixis
Regeneron
Innovent
Hengrui Medicine
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Personalized Cancer Medicine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Personalized Cancer Medicine, with revenue, gross margin and global market share of Personalized Cancer Medicine from 2018 to 2023.
Chapter 3, the Personalized Cancer Medicine competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Method and application, with consumption value and growth rate by Method, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Personalized Cancer Medicine market forecast, by regions, method and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Personalized Cancer Medicine.
Chapter 13, to describe Personalized Cancer Medicine research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope of Personalized Cancer Medicine
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Personalized Cancer Medicine by Method
- 1.3.1 Overview: Global Personalized Cancer Medicine Market Size by Method: 2018 Versus 2022 Versus 2029
- 1.3.2 Global Personalized Cancer Medicine Consumption Value Market Share by Method in 2022
- 1.3.3 Cancer Immunotherapy
- 1.3.4 Targeted Therapy
- 1.4 Global Personalized Cancer Medicine Market by Application
- 1.4.1 Overview: Global Personalized Cancer Medicine Market Size by Application: 2018 Versus 2022 Versus 2029
- 1.4.2 Lung Cancer
- 1.4.3 Breast Cancer
- 1.4.4 Prostate Cancer
- 1.4.5 Blood-related Cancer
- 1.4.6 Other
- 1.5 Global Personalized Cancer Medicine Market Size & Forecast
- 1.6 Global Personalized Cancer Medicine Market Size and Forecast by Region
- 1.6.1 Global Personalized Cancer Medicine Market Size by Region: 2018 VS 2022 VS 2029
- 1.6.2 Global Personalized Cancer Medicine Market Size by Region, (2018-2029)
- 1.6.3 North America Personalized Cancer Medicine Market Size and Prospect (2018-2029)
- 1.6.4 Europe Personalized Cancer Medicine Market Size and Prospect (2018-2029)
- 1.6.5 Asia-Pacific Personalized Cancer Medicine Market Size and Prospect (2018-2029)
- 1.6.6 South America Personalized Cancer Medicine Market Size and Prospect (2018-2029)
- 1.6.7 Middle East and Africa Personalized Cancer Medicine Market Size and Prospect (2018-2029)
2 Company Profiles
- 2.1 AbbVie
- 2.1.1 AbbVie Details
- 2.1.2 AbbVie Major Business
- 2.1.3 AbbVie Personalized Cancer Medicine Product and Solutions
- 2.1.4 AbbVie Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023)
- 2.1.5 AbbVie Recent Developments and Future Plans
- 2.2 Johnson & Johnson
- 2.2.1 Johnson & Johnson Details
- 2.2.2 Johnson & Johnson Major Business
- 2.2.3 Johnson & Johnson Personalized Cancer Medicine Product and Solutions
- 2.2.4 Johnson & Johnson Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023)
- 2.2.5 Johnson & Johnson Recent Developments and Future Plans
- 2.3 Novartis
- 2.3.1 Novartis Details
- 2.3.2 Novartis Major Business
- 2.3.3 Novartis Personalized Cancer Medicine Product and Solutions
- 2.3.4 Novartis Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023)
- 2.3.5 Novartis Recent Developments and Future Plans
- 2.4 Gilead Sciences
- 2.4.1 Gilead Sciences Details
- 2.4.2 Gilead Sciences Major Business
- 2.4.3 Gilead Sciences Personalized Cancer Medicine Product and Solutions
- 2.4.4 Gilead Sciences Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023)
- 2.4.5 Gilead Sciences Recent Developments and Future Plans
- 2.5 Roche
- 2.5.1 Roche Details
- 2.5.2 Roche Major Business
- 2.5.3 Roche Personalized Cancer Medicine Product and Solutions
- 2.5.4 Roche Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023)
- 2.5.5 Roche Recent Developments and Future Plans
- 2.6 Bristol-Myers Squibb
- 2.6.1 Bristol-Myers Squibb Details
- 2.6.2 Bristol-Myers Squibb Major Business
- 2.6.3 Bristol-Myers Squibb Personalized Cancer Medicine Product and Solutions
- 2.6.4 Bristol-Myers Squibb Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023)
- 2.6.5 Bristol-Myers Squibb Recent Developments and Future Plans
- 2.7 Amgen
- 2.7.1 Amgen Details
- 2.7.2 Amgen Major Business
- 2.7.3 Amgen Personalized Cancer Medicine Product and Solutions
- 2.7.4 Amgen Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023)
- 2.7.5 Amgen Recent Developments and Future Plans
- 2.8 AstraZeneca
- 2.8.1 AstraZeneca Details
- 2.8.2 AstraZeneca Major Business
- 2.8.3 AstraZeneca Personalized Cancer Medicine Product and Solutions
- 2.8.4 AstraZeneca Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023)
- 2.8.5 AstraZeneca Recent Developments and Future Plans
- 2.9 Merck & Co
- 2.9.1 Merck & Co Details
- 2.9.2 Merck & Co Major Business
- 2.9.3 Merck & Co Personalized Cancer Medicine Product and Solutions
- 2.9.4 Merck & Co Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023)
- 2.9.5 Merck & Co Recent Developments and Future Plans
- 2.10 Takeda
- 2.10.1 Takeda Details
- 2.10.2 Takeda Major Business
- 2.10.3 Takeda Personalized Cancer Medicine Product and Solutions
- 2.10.4 Takeda Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023)
- 2.10.5 Takeda Recent Developments and Future Plans
- 2.11 Merck KGaA
- 2.11.1 Merck KGaA Details
- 2.11.2 Merck KGaA Major Business
- 2.11.3 Merck KGaA Personalized Cancer Medicine Product and Solutions
- 2.11.4 Merck KGaA Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023)
- 2.11.5 Merck KGaA Recent Developments and Future Plans
- 2.12 Seagen
- 2.12.1 Seagen Details
- 2.12.2 Seagen Major Business
- 2.12.3 Seagen Personalized Cancer Medicine Product and Solutions
- 2.12.4 Seagen Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023)
- 2.12.5 Seagen Recent Developments and Future Plans
- 2.13 Eli Lilly
- 2.13.1 Eli Lilly Details
- 2.13.2 Eli Lilly Major Business
- 2.13.3 Eli Lilly Personalized Cancer Medicine Product and Solutions
- 2.13.4 Eli Lilly Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023)
- 2.13.5 Eli Lilly Recent Developments and Future Plans
- 2.14 Ono Pharmaceutical
- 2.14.1 Ono Pharmaceutical Details
- 2.14.2 Ono Pharmaceutical Major Business
- 2.14.3 Ono Pharmaceutical Personalized Cancer Medicine Product and Solutions
- 2.14.4 Ono Pharmaceutical Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023)
- 2.14.5 Ono Pharmaceutical Recent Developments and Future Plans
- 2.15 Pfizer
- 2.15.1 Pfizer Details
- 2.15.2 Pfizer Major Business
- 2.15.3 Pfizer Personalized Cancer Medicine Product and Solutions
- 2.15.4 Pfizer Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023)
- 2.15.5 Pfizer Recent Developments and Future Plans
- 2.16 GSK
- 2.16.1 GSK Details
- 2.16.2 GSK Major Business
- 2.16.3 GSK Personalized Cancer Medicine Product and Solutions
- 2.16.4 GSK Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023)
- 2.16.5 GSK Recent Developments and Future Plans
- 2.17 Exelixis
- 2.17.1 Exelixis Details
- 2.17.2 Exelixis Major Business
- 2.17.3 Exelixis Personalized Cancer Medicine Product and Solutions
- 2.17.4 Exelixis Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023)
- 2.17.5 Exelixis Recent Developments and Future Plans
- 2.18 Regeneron
- 2.18.1 Regeneron Details
- 2.18.2 Regeneron Major Business
- 2.18.3 Regeneron Personalized Cancer Medicine Product and Solutions
- 2.18.4 Regeneron Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023)
- 2.18.5 Regeneron Recent Developments and Future Plans
- 2.19 Innovent
- 2.19.1 Innovent Details
- 2.19.2 Innovent Major Business
- 2.19.3 Innovent Personalized Cancer Medicine Product and Solutions
- 2.19.4 Innovent Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023)
- 2.19.5 Innovent Recent Developments and Future Plans
- 2.20 Hengrui Medicine
- 2.20.1 Hengrui Medicine Details
- 2.20.2 Hengrui Medicine Major Business
- 2.20.3 Hengrui Medicine Personalized Cancer Medicine Product and Solutions
- 2.20.4 Hengrui Medicine Personalized Cancer Medicine Revenue, Gross Margin and Market Share (2018-2023)
- 2.20.5 Hengrui Medicine Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Personalized Cancer Medicine Revenue and Share by Players (2018-2023)
- 3.2 Market Share Analysis (2022)
- 3.2.1 Market Share of Personalized Cancer Medicine by Company Revenue
- 3.2.2 Top 3 Personalized Cancer Medicine Players Market Share in 2022
- 3.2.3 Top 6 Personalized Cancer Medicine Players Market Share in 2022
- 3.3 Personalized Cancer Medicine Market: Overall Company Footprint Analysis
- 3.3.1 Personalized Cancer Medicine Market: Region Footprint
- 3.3.2 Personalized Cancer Medicine Market: Company Product Type Footprint
- 3.3.3 Personalized Cancer Medicine Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Method
- 4.1 Global Personalized Cancer Medicine Consumption Value and Market Share by Method (2018-2023)
- 4.2 Global Personalized Cancer Medicine Market Forecast by Method (2024-2029)
5 Market Size Segment by Application
- 5.1 Global Personalized Cancer Medicine Consumption Value Market Share by Application (2018-2023)
- 5.2 Global Personalized Cancer Medicine Market Forecast by Application (2024-2029)
6 North America
- 6.1 North America Personalized Cancer Medicine Consumption Value by Method (2018-2029)
- 6.2 North America Personalized Cancer Medicine Consumption Value by Application (2018-2029)
- 6.3 North America Personalized Cancer Medicine Market Size by Country
- 6.3.1 North America Personalized Cancer Medicine Consumption Value by Country (2018-2029)
- 6.3.2 United States Personalized Cancer Medicine Market Size and Forecast (2018-2029)
- 6.3.3 Canada Personalized Cancer Medicine Market Size and Forecast (2018-2029)
- 6.3.4 Mexico Personalized Cancer Medicine Market Size and Forecast (2018-2029)
7 Europe
- 7.1 Europe Personalized Cancer Medicine Consumption Value by Method (2018-2029)
- 7.2 Europe Personalized Cancer Medicine Consumption Value by Application (2018-2029)
- 7.3 Europe Personalized Cancer Medicine Market Size by Country
- 7.3.1 Europe Personalized Cancer Medicine Consumption Value by Country (2018-2029)
- 7.3.2 Germany Personalized Cancer Medicine Market Size and Forecast (2018-2029)
- 7.3.3 France Personalized Cancer Medicine Market Size and Forecast (2018-2029)
- 7.3.4 United Kingdom Personalized Cancer Medicine Market Size and Forecast (2018-2029)
- 7.3.5 Russia Personalized Cancer Medicine Market Size and Forecast (2018-2029)
- 7.3.6 Italy Personalized Cancer Medicine Market Size and Forecast (2018-2029)
8 Asia-Pacific
- 8.1 Asia-Pacific Personalized Cancer Medicine Consumption Value by Method (2018-2029)
- 8.2 Asia-Pacific Personalized Cancer Medicine Consumption Value by Application (2018-2029)
- 8.3 Asia-Pacific Personalized Cancer Medicine Market Size by Region
- 8.3.1 Asia-Pacific Personalized Cancer Medicine Consumption Value by Region (2018-2029)
- 8.3.2 China Personalized Cancer Medicine Market Size and Forecast (2018-2029)
- 8.3.3 Japan Personalized Cancer Medicine Market Size and Forecast (2018-2029)
- 8.3.4 South Korea Personalized Cancer Medicine Market Size and Forecast (2018-2029)
- 8.3.5 India Personalized Cancer Medicine Market Size and Forecast (2018-2029)
- 8.3.6 Southeast Asia Personalized Cancer Medicine Market Size and Forecast (2018-2029)
- 8.3.7 Australia Personalized Cancer Medicine Market Size and Forecast (2018-2029)
9 South America
- 9.1 South America Personalized Cancer Medicine Consumption Value by Method (2018-2029)
- 9.2 South America Personalized Cancer Medicine Consumption Value by Application (2018-2029)
- 9.3 South America Personalized Cancer Medicine Market Size by Country
- 9.3.1 South America Personalized Cancer Medicine Consumption Value by Country (2018-2029)
- 9.3.2 Brazil Personalized Cancer Medicine Market Size and Forecast (2018-2029)
- 9.3.3 Argentina Personalized Cancer Medicine Market Size and Forecast (2018-2029)
10 Middle East & Africa
- 10.1 Middle East & Africa Personalized Cancer Medicine Consumption Value by Method (2018-2029)
- 10.2 Middle East & Africa Personalized Cancer Medicine Consumption Value by Application (2018-2029)
- 10.3 Middle East & Africa Personalized Cancer Medicine Market Size by Country
- 10.3.1 Middle East & Africa Personalized Cancer Medicine Consumption Value by Country (2018-2029)
- 10.3.2 Turkey Personalized Cancer Medicine Market Size and Forecast (2018-2029)
- 10.3.3 Saudi Arabia Personalized Cancer Medicine Market Size and Forecast (2018-2029)
- 10.3.4 UAE Personalized Cancer Medicine Market Size and Forecast (2018-2029)
11 Market Dynamics
- 11.1 Personalized Cancer Medicine Market Drivers
- 11.2 Personalized Cancer Medicine Market Restraints
- 11.3 Personalized Cancer Medicine Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Personalized Cancer Medicine Industry Chain
- 12.2 Personalized Cancer Medicine Upstream Analysis
- 12.3 Personalized Cancer Medicine Midstream Analysis
- 12.4 Personalized Cancer Medicine Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Personalized Cancer Medicine. Industry analysis & Market Report on Personalized Cancer Medicine is a syndicated market report, published as Global Personalized Cancer Medicine Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Personalized Cancer Medicine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
